摘要
最近,纳米粒子使针对细胞组织的治疗药物的靶向给药成为可能,这对基础生物科学,制药工业,临床前医学和转化医学造成了重大影响。这些材料的对药代动力学,生物分布和治疗分子的长期活动进行改造以适应特殊疾病和避免不良反应的能力是很有前途的。但是来自体循环的靶向纳米粒子的治疗效率很低,而且我们对体内活动的基本过程的传导了解有限。因此,我们很难作出这些材料的最佳合理设计以期达到最大效能。最近,多模式和多尺度成像技术的兴起有助于我们对这些过程的进一步认识。治疗诊断成像剂能给出实时的量化的药物分布和治疗反应的显示值,多模式成像平台可以进行从细胞到组织水平的分布的多尺度分析,而且令人振奋的是,在活体组织镜检中应用提供了细胞水平上的关键认识。在这篇综述中,我们讲述了多尺度成像如何使我们能够完善纳米药物,并且讨论了进一步促进其临床转化的未来方向。
关键词: 增强的通透性和保留,荧光,活体镜检,核磁共振成像,纳米材料,纳米药物,纳米技术,正电子发射体层摄影,量子点。
Current Drug Targets
Title:Multiscale Imaging of Nanoparticle Drug Delivery
Volume: 16 Issue: 6
Author(s): Lawrence W. Dobrucki, Dipanjan Pan and Andrew M. Smith
Affiliation:
关键词: 增强的通透性和保留,荧光,活体镜检,核磁共振成像,纳米材料,纳米药物,纳米技术,正电子发射体层摄影,量子点。
摘要: Nanoparticles have recently had a major impact on basic biosciences, the pharmaceutical industry, and preclinical and translational medicine by enabling targeted delivery of therapeutic cargo to cells and tissues. The capacity to specifically tailor the pharmacokinetics, biodistribution, and longterm fate of therapeutic molecules for specific diseases and to avoid off-target side effects is a tremendously promising capability of these materials. However targeting of nanoparticle therapies from systemic circulation is very inefficient, and our understanding of the fundamental processes dictating in vivo fate remains limited, making it challenging to determine how to optimally and rationally design these materials for maximum efficacy. Recently multi-modal, multi-scale imaging technologies have emerged that have helped to improve our insight into these processes. Theranostic imaging agents have provided real-time and quantitative readouts of drug distribution and therapeutic response, multimodal imaging platforms have allowed a multi-scale analysis of distribution from the levels of cells to tissues, and exciting applications in live-animal tissue microscopy have provided key insights at the cellular level. In this review, we describe how multiscale imaging has shaped our ability to optimize nanoparticle drugs and discuss future directions that are expected to further catalyze clinical translation.
Export Options
About this article
Cite this article as:
Lawrence W. Dobrucki, Dipanjan Pan and Andrew M. Smith , Multiscale Imaging of Nanoparticle Drug Delivery, Current Drug Targets 2015; 16 (6) . https://dx.doi.org/10.2174/1389450116666150202163022
DOI https://dx.doi.org/10.2174/1389450116666150202163022 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Moderate Hypothermia in the Management of Severe Traumatic Brain Injury: A Good Idea Proved Ineffective?
Current Pharmaceutical Design Editorial: Neuronanomedicine - (Part II)
Current Medicinal Chemistry Management of Blood Pressure and Heart Rate in Patients with Acute Stroke
Current Pharmaceutical Design Inherited Renal Diseases
Current Pediatric Reviews Patent Selections
Recent Patents on DNA & Gene Sequences Subject Index To Volume 3
Vascular Disease Prevention (Discontinued) A Clinical Perspective of Soluble Epoxide Hydrolase Inhibitors in Metabolic and Related Cardiovascular Diseases
Current Molecular Pharmacology Cardiovascular Complications in Patients with Turner’s Syndrome
Current Pharmaceutical Design Spreading Depolarization Waves in Neurological Diseases: A Short Review about its Pathophysiology and Clinical Relevance
Current Neuropharmacology Pharmacological Neuroprotection in Stroke: Rationale, State-of-the-art and Future Directions
Current Neuropharmacology Arterial Dilatation-Related Diseases: The Prerequisite Condition of Arterial Elastic Tissue Damage and Endovascular Treatment
Recent Patents on Medical Imaging Intracranial Aneurysms; In Need of Early Diagnostic and Treatment Using Bio- and Nanotechnology
Current Medicinal Chemistry Common and Uncommon Features of Rheumatoid Arthritis and Chronic Obstructive Pulmonary Disease: Clues to a Future Therapy
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Update on the Pathophysiological Role of Intracellular Signaling Pathways in Atherosclerotic Plaques and Ischemic Myocardium
Current Signal Transduction Therapy Statin Use and Cardiovascular Event/Death Rates After Abdominal Aortic Aneurysm Repair Procedures
Current Vascular Pharmacology Therapeutic Hypothermia as a Neuroprotective Strategy in Neonatal Hypoxic-Ischemic Brain Injury and Traumatic Brain Injury
Current Molecular Medicine Rheumatic Manifestations in Malignancy
Current Rheumatology Reviews Endovascular Versus Open Abdominal Aortic Aneurysm: Best Decision
Current Pharmaceutical Design Patent Selections:
Recent Patents on Anti-Infective Drug Discovery Innate Immune Inflammatory Response in the Acutely Ischemic Myocardium
Medicinal Chemistry